DOCSLIB.ORG

Genotypeephenotype Correlation in CC2D2A-Related Joubert Syndrome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Downloaded from jmg.bmj.com on January 18, 2012 - Published by group.bmj.com Genotype-phenotype correlations ORIGINAL ARTICLE Genotypeephenotype correlation in CC2D2A-related Joubert syndrome reveals an association with ventriculomegaly and seizures Ruxandra Bachmann-Gagescu,1 Gisele E Ishak,2 Jennifer C Dempsey,1 Jonathan Adkins,1 Diana O’Day,1 Ian G Phelps,1 Meral Gunay-Aygun,3 Antonie D Kline,4 Krzysztof Szczaluba,5 Loreto Martorell,6 Abdulrahman Alswaid,7 Shatha Alrasheed,7 Shashidhar Pai,8 Louise Izatt,9 Anne Ronan,10 Melissa A Parisi,11 Heather Mefford,1 Ian Glass,1 Dan Doherty1,12 For numbered affiliations see ABSTRACT junction.1 2 Patients with JS manifest hypotonia, end of article. Background Joubert syndrome (JS) is a ciliopathy ataxia, developmental delay, abnormal eye move- characterised by a distinctive brain malformation (the ments and abnormal respiratory control.34In Correspondence to Dr Dan Doherty, Associate ‘molar tooth sign’), developmental delay, abnormal eye addition to the core neurological features, subsets Professor, Divisions of Genetic movements and abnormal breathing pattern. Retinal of patients with JS also display abnormalities in Medicine and Developmental dystrophy, cystic kidney disease, liver fibrosis and other organ systems, including retinal dystrophy, Medicine, University of polydactyly are variably present, resulting in significant chorioretinal coloboma, cystic kidney disease, liver Washington, Box 356320, phenotypic heterogeneity and overlap with other fi 5 RR-249, 1959 NE Pacific Street, brosis and polydactyly. Given this pleiotropic Seattle, WA 98195-6320, USA; ciliopathies. JS is also genetically heterogeneous, phenotypic presentation, substantial overlap with [email protected] resulting from mutations in 13 genes. These factors other disorders is observed, including Meckel, render clinical/molecular diagnosis and management SenioreLøken and BardeteBiedl syndromes, as well Received 5 October 2011 challenging. CC2D2A mutations are a relatively common as Leber congenital amaurosis and isolated neph- Revised 7 December 2011 fi Accepted 8 December 2011 cause of JS and also cause Meckel syndrome. The ronophthisis. These disorders have been classi ed as clinical consequences of CC2D2A mutations in patients ciliopathies, since their causative genes all encode with JS have been incompletely reported. proteins involved in function of primary cilia, Methods Subjects with JS from 209 families were ubiquitous organelles essential in mechanical, evaluated to identify mutations in CC2D2A. Clinical and chemical and light transduction, as well as specific imaging features in subjects with CC2D2A mutations signalling pathways.6 were compared with those in subjects without CC2D2A JS, like most ciliopathies, is characterised by mutations and reports in the literature. significant genetic heterogeneity, since 13 causative Results 10 novel CC2D2A mutations in 20 subjects genes have been identified to date: AHI1, ARL13B, were identified; a summary is provided of all published CC2D2A, CEP290, INPP5E, KIF7, NPHP1, OFD1, CC2D2A mutations. Subjects with CC2D2A-related JS RPGRIP1L, TCTN1, TCTN2, TMEM67 (MKS3) and e were more likely to have ventriculomegaly (p<0.0001) TMEM216.7 20 These account individually for up and seizures (p¼0.024) than subjects without CC2D2A to 10% and collectively for w50% of patients with mutations. No mutation-specific genotypeephenotype JS, indicating that many genes are yet to be iden- correlations could be identified, but the findings confirm tified. In addition to the phenotypic overlap the observation that mutations that cause CC2D2A- between ciliopathies, significant genetic overlap is related JS are predicted to be less deleterious than observed, particularly between JS and Meckel mutations that cause CC2D2A-related Meckel syndrome. syndrome (MKS), which is characterised by ence- Missense variants in the coiled-coil and C2 domains, as phalocele, cystic/dysplastic kidney disease, ductal well as the C-terminal region, identify these regions as plate malformation of the liver, polydactyly and, important for the biological mechanisms underlying JS. typically, fetal or neonatal lethality.21 Of the 13 Conclusions CC2D2A testing should be prioritised in genes responsible for JS, six also cause MKS patients with JS and ventriculomegaly and/or seizures. (CC2D2A,21 CEP290,22 RPGRIP1L,23 TCTN2,24 Patients with CC2D2A-related JS should be monitored TMEM6712 and TMEM21614), leading to the for hydrocephalus and seizures. concept that some forms of JS and MKS represent mild and severe presentations of the same biological disorder. Consistent with this concept, patients with MKS more often have truncating mutations INTRODUCTION in CC2D2A, and patients with JS more often have Joubert syndrome (JS) is a recessive disorder char- at least one missense mutation.21 Of note, no other acterised by cerebellar vermis hypoplasia, thick- genotypeephenotype correlations have been ened, mis-oriented superior cerebellar peduncles reported in patients with CC2D2A mutations. and an abnormally deep interpeduncular fossa CC2D2A mutations represent a major cause of resulting in the pathognomonic ‘molar tooth sign’ both JS and MKS since they are responsible for (MTS) on axial imaging of the mid-hind brain w10% of each disorder.4 721CC2D2A encodes 126 J Med Genet 2012;49:126e137. doi:10.1136/jmedgenet-2011-100552 J Med Genet Table 1 Summary of phenotypic information in subjects with CC2D2A mutations, single heterozygous variants, and variants of unclear functional significance identified in this cohort CC2D2A CC2D2A P2 score, Ctrl allele % Age Identification no mutations, cDNA mutations, protein Div/Var EU/AA (years) MTS EC DD/ ID Sz A/T Nyst, OMA RD Kidney Liver PD Other 2012; CC2D2A mutations and phenotypic summary UW36-37 c.3364C>T homM,P p.P1122S 1.0/0.99 0 8 + e + e + eeeee 49 UW41-37 c.2848C>T homM,P p.R950X hom 04+e + ee ++eeeCortic vis imp :126 UW46-1 N c.3289 delGP p.V1097Ffs*1 ND 19 + e + ee + ee e e e c.4289T>CM p.V1430A 1.0/0.86 0 137. doi:10.1136/jmedgenet-2011-100552 UW46-2 N c.3289 delGP p.V1097Ffs*1 ND 22 + e + ee + ee e eScoliosis c.4289T>CM p.V1430A 1.0/0.86 0 UW47-37 c.3055C>TM p.R1019X 0 19 + e ++++ ee e e Downloaded from c.3288G>CP p.Q1096H 0.64/0.12 0 UW48-37 c.3364C>T homM,P p.P1122S 1.0/0.99 0 7* + e + e + + + + (ESRF/TXPT) eeScoliosis UW49-330 c.3289 delGM p.V1097Ffs*1 ND 24 + e ++++ e + + (TXPT) e Coloboma c.4582C>TP p.R1528C 1.0/0.97 0 COACH UW50-37 c.4582C>T homM,P p.R1528C hom 1.0/0.97 0 12 + e + ee e ee e eSibling w/ EC UW50-67 c.4582C>T homM,P p.R1528C hom 1.0/0.97 0 8 + + + ee e ee e e jmg.bmj.com UW67-330 c.3145C>T p.R1049X 0 7+e + e ++ e + + fibrosis e c.3347C>T p.T1116M 1.0/0.97 0.03/0 UW75-3N c.1676T>CM p.L559P 1.0/0.99 0 18 + e + e ++ ee e e c.3892_3 del(GT)P p.V1298Ffs*16 ND N P UW76-3 c.3134T>C p.V1045A 0.98/0.6 0 3+e + e + eeeee onJanuary18,2012-Publishedby c.3850C>TM p.R1284C 1.0/1.0 0 UW78-3 N c.3055C>TM p.R1019X 0 1+e + ee + e ND ND e c.4667A>TP p.D1556V 0.98/0.74 0.03/0.03 UW79-3 N c.(1263_4InsGGCATGT p.S423Gfs*19 ND 26 + e + e ++ ee e e TTTGGC; c.1268G>A)P p.V1151A 1.0/0.39 0 c.3452T>CM 0 UW79-4 N c.(1263_4InsGGCATGT p.S423Gfs*19 ND 24 + e ++++ ee e e TTTGGC; 1268G>A)P p.V1151A 1.0/0.39 0 c.3452T>CM 0 UW80-3 c.3289 delG p.V1097Ffs*1 ND 1+e +++ND e + (cysts) ND e c.3347C>T p.T1116M 1.0/0.97 0.03/0 UW81-3 N c.4179+1delG p.E1393Efs*1 ND 11 + e + ee + ee e e c.4667A>T p.D1556V 0.98/0.74 0.03/0.03 N P Genotype-phenotype correlations UW82-3 c.3976-3C>A p.IVS30(-3) 0 8+e ++++ ee e e group.bmj.com c.4844_4847delCTCTM p.S1615Lfs*15 ND UW102-3 N c.3772-1G>TP p.IVS29(-1) 0 4+e + e + eeeeND Cortic vis imp c.4582C>TM p.R1528C 1.0/0.97 0 UW103-3 N c.3289delG p.V1097Ffs*1 ND 3+e + ee e ee e eSibling w/ MKS c.3851G>A p.R1284H 1.0/1.0 0 n¼20 subjects from 17 families 20/20 1/20 20/20 5/20 12/20 13/19 2/20 4/19 2/18 0/19 Single heterozygous changes and variants of unclear significance UW06-3 N c.351T>G p.S117R 0.84/0.36 0.2/0.07 14 + e + +F + + + + (ESRF, TXPT) eeVPI UW54-3 c.1519A>G p.K507E 0.99/0.70 0.8/0.08 10 + e + e ++ e + (ESRF, TXPT) + (TXPT) e Coloboma TMEM67 UW88-3 N c.3989G>A p.R1330Q 1.0/0.94 0 10 + e + ee + ee e e UW88-4 N c.3989G>A p.R1330Q 1.0/0.94 0 13 + e + ee e ee e e UW106-3 c.4667A>T p.D1556V 0.98/0.74 0.03/0.03 4 + e + ee e ee e e 127 Continued 128 Table 1 Continued Genotype-phenotype correlations CC2D2A CC2D2A P2 score, Ctrl allele % Age Identification no mutations, cDNA mutations, protein Div/Var EU/AA (years) MTS EC DD/ ID Sz A/T Nyst, OMA RD Kidney Liver PD Other UW107-3 c.1519A>G p.K507E 0.99/0.70 0.8/0.08 2 + e + ee + ee e eTwins UW107-4 c.1519A>G p.K507E 0.99/0.70 0.8/0.08 2 + e + ee + ee e e UW108-3 N c.3055C>T p.R1019X 01NDe + e ND + + ND ND ND Sibling with MTS UW109-3 ND c.3347C>T p.T1116M 1.0/0.97 0.03/0 2 + e + ee +NDNDNDe ND UW110-3N c.2101C>G p.L701V 0.05/0.02 0 <1* + e + e + ND ND + ND + UW111-3N c.351T>G p.S117R 0.84/0.36 0.2/0.07 2 + e + e ++ ee ND + Coloboma TCTN2 Downloaded from UW77-3 N c.1978G>A p.V660I 0.004/0.005 0.01/2.4 13 + e ++++ ee e e c.2050T>A p.L684I 0.003/0.004 0/0.5 UW104-3 N c.685_687delGAA p.E229del 3/ND <1+e + e +NDNDeeeDextro-cardia c.1017+1G>A p.IVS11(+1) 0/0.03 UW105-3 c.685_687delGAA p.E229del 3/ND 6+e + +NN + + ee e e c.4667A>T p.D1556V 0.98/0.74 0.03/0.03 Nonsense or frameshift mutations are in bold.
Recommended publications
  • Ciliopathiesneuromuscularciliopathies Disorders Disorders Ciliopathiesciliopathies

    Ciliopathiesneuromuscularciliopathies Disorders Disorders Ciliopathiesciliopathies

    NeuromuscularCiliopathiesNeuromuscularCiliopathies Disorders Disorders CiliopathiesCiliopathies AboutAbout EGL EGL Genet Geneticsics EGLEGL Genetics Genetics specializes specializes in ingenetic genetic diagnostic diagnostic testing, testing, with with ne nearlyarly 50 50 years years of of clinical clinical experience experience and and board-certified board-certified labor laboratoryatory directorsdirectors and and genetic genetic counselors counselors reporting reporting out out cases. cases. EGL EGL Genet Geneticsics offers offers a combineda combined 1000 1000 molecular molecular genetics, genetics, biochemical biochemical genetics,genetics, and and cytogenetics cytogenetics tests tests under under one one roof roof and and custom custom test testinging for for all all medically medically relevant relevant genes, genes, for for domestic domestic andand international international clients. clients. EquallyEqually important important to to improving improving patient patient care care through through quality quality genetic genetic testing testing is is the the contribution contribution EGL EGL Genetics Genetics makes makes back back to to thethe scientific scientific and and medical medical communities. communities. EGL EGL Genetics Genetics is is one one of of only only a afew few clinical clinical diagnostic diagnostic laboratories laboratories to to openly openly share share data data withwith the the NCBI NCBI freely freely available available public public database database ClinVar ClinVar (>35,000 (>35,000 variants variants on on >1700 >1700 genes) genes) and and is isalso also the the only only laboratory laboratory with with a a frefree oen olinnlein dea dtabtaabsaes (eE m(EVmCVlaCslas)s,s f)e, afetuatruinrgin ag vaa vraiarniatn ctl acslasisfiscifiactiaotino sne saercahrc ahn adn rde rpeoprot rrte rqeuqeuset sint tinetrefarcfaec, ew, hwichhic fha cfailcitialiteatse rsa praidp id interactiveinteractive curation curation and and reporting reporting of of variants.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Ciliopathy-Associated Gene Cc2d2a Promotes Assembly of Subdistal Appendages on the Mother Centriole During Cilia Biogenesis

    Ciliopathy-Associated Gene Cc2d2a Promotes Assembly of Subdistal Appendages on the Mother Centriole During Cilia Biogenesis

    ARTICLE Received 7 Apr 2014 | Accepted 23 May 2014 | Published 20 Jun 2014 DOI: 10.1038/ncomms5207 Ciliopathy-associated gene Cc2d2a promotes assembly of subdistal appendages on the mother centriole during cilia biogenesis Shobi Veleri1, Souparnika H. Manjunath1, Robert N. Fariss2, Helen May-Simera1, Matthew Brooks1, Trevor A. Foskett1, Chun Gao2, Teresa A. Longo1, Pinghu Liu3, Kunio Nagashima4, Rivka A. Rachel1, Tiansen Li1, Lijin Dong3 & Anand Swaroop1 The primary cilium originates from the mother centriole and participates in critical functions during organogenesis. Defects in cilia biogenesis or function lead to pleiotropic phenotypes. Mutations in centrosome-cilia gene CC2D2A result in Meckel and Joubert syndromes. Here we generate a Cc2d2a À / À mouse that recapitulates features of Meckel syndrome including embryonic lethality and multiorgan defects. Cilia are absent in Cc2d2a À / À embryonic node and other somatic tissues; disruption of cilia-dependent Shh signalling appears to underlie exencephaly in mutant embryos. The Cc2d2a À / À mouse embryonic fibroblasts (MEFs) lack cilia, although mother centrioles and pericentriolar pro- teins are detected. Odf2, associated with subdistal appendages, is absent and ninein is reduced in mutant MEFs. In Cc2d2a À / À MEFs, subdistal appendages are lacking or abnormal by transmission electron microscopy. Consistent with this, CC2D2A localizes to subdistal appendages by immuno-EM in wild-type cells. We conclude that CC2D2A is essential for the assembly of subdistal appendages, which anchor cytoplasmic microtubules and prime the mother centriole for axoneme biogenesis. 1 Neurobiology-Neurodegeneration and Repair Laboratory, National Eye Institute, NIH, Bethesda, Maryland 20892, USA. 2 Biological Imaging Core, National Eye Institute, NIH, Bethesda, Maryland 20892, USA.
  • Ciliopathies Gene Panel

    Ciliopathies Gene Panel

    Ciliopathies Gene Panel Contact details Introduction Regional Genetics Service The ciliopathies are a heterogeneous group of conditions with considerable phenotypic overlap. Levels 4-6, Barclay House These inherited diseases are caused by defects in cilia; hair-like projections present on most 37 Queen Square cells, with roles in key human developmental processes via their motility and signalling functions. Ciliopathies are often lethal and multiple organ systems are affected. Ciliopathies are London, WC1N 3BH united in being genetically heterogeneous conditions and the different subtypes can share T +44 (0) 20 7762 6888 many clinical features, predominantly cystic kidney disease, but also retinal, respiratory, F +44 (0) 20 7813 8578 skeletal, hepatic and neurological defects in addition to metabolic defects, laterality defects and polydactyly. Their clinical variability can make ciliopathies hard to recognise, reflecting the ubiquity of cilia. Gene panels currently offer the best solution to tackling analysis of genetically Samples required heterogeneous conditions such as the ciliopathies. Ciliopathies affect approximately 1:2,000 5ml venous blood in plastic EDTA births. bottles (>1ml from neonates) Ciliopathies are generally inherited in an autosomal recessive manner, with some autosomal Prenatal testing must be arranged dominant and X-linked exceptions. in advance, through a Clinical Genetics department if possible. Referrals Amniotic fluid or CV samples Patients presenting with a ciliopathy; due to the phenotypic variability this could be a diverse set should be sent to Cytogenetics for of features. For guidance contact the laboratory or Dr Hannah Mitchison dissecting and culturing, with ([email protected]) / Prof Phil Beales ([email protected]) instructions to forward the sample to the Regional Molecular Genetics Referrals will be accepted from clinical geneticists and consultants in nephrology, metabolic, laboratory for analysis respiratory and retinal diseases.
  • The Role of Primary Cilia in the Crosstalk Between the Ubiquitin–Proteasome System and Autophagy

    The Role of Primary Cilia in the Crosstalk Between the Ubiquitin–Proteasome System and Autophagy

    cells Review The Role of Primary Cilia in the Crosstalk between the Ubiquitin–Proteasome System and Autophagy Antonia Wiegering, Ulrich Rüther and Christoph Gerhardt * Institute for Animal Developmental and Molecular Biology, Heinrich Heine University, 40225 Düsseldorf, Germany; [email protected] (A.W.); [email protected] (U.R.) * Correspondence: [email protected]; Tel.: +49-(0)211-81-12236 Received: 29 December 2018; Accepted: 11 March 2019; Published: 14 March 2019 Abstract: Protein degradation is a pivotal process for eukaryotic development and homeostasis. The majority of proteins are degraded by the ubiquitin–proteasome system and by autophagy. Recent studies describe a crosstalk between these two main eukaryotic degradation systems which allows for establishing a kind of safety mechanism. If one of these degradation systems is hampered, the other compensates for this defect. The mechanism behind this crosstalk is poorly understood. Novel studies suggest that primary cilia, little cellular protrusions, are involved in the regulation of the crosstalk between the two degradation systems. In this review article, we summarise the current knowledge about the association between cilia, the ubiquitin–proteasome system and autophagy. Keywords: protein aggregation; neurodegenerative diseases; OFD1; BBS4; RPGRIP1L; hedgehog; mTOR; IFT; GLI 1. Introduction Protein aggregates are huge protein accumulations that develop as a consequence of misfolded proteins. The occurrence of protein aggregates is associated with the development of neurodegenerative diseases, such as Huntington’s disease, prion disorders, Alzheimer’s disease and Parkinson’s disease [1–3], demonstrating that the degradation of incorrectly folded proteins is of eminent importance for human health. In addition to the destruction of useless and dangerous proteins (protein quality control), protein degradation is an important process to regulate the cell cycle, to govern transcription and also to control intra- and intercellular signal transduction [4–6].
  • Active Transport and Diffusion Barriers Restrict Joubert Syndrome-Associated ARL13B/ARL-13 to an Inv-Like Ciliary Membrane Subdomain

    Active Transport and Diffusion Barriers Restrict Joubert Syndrome-Associated ARL13B/ARL-13 to an Inv-Like Ciliary Membrane Subdomain

    Active Transport and Diffusion Barriers Restrict Joubert Syndrome-Associated ARL13B/ARL-13 to an Inv-like Ciliary Membrane Subdomain Sebiha Cevik1, Anna A. W. M. Sanders1., Erwin Van Wijk2,3,4., Karsten Boldt5., Lara Clarke1, Jeroen van Reeuwijk3,6,7, Yuji Hori8, Nicola Horn5, Lisette Hetterschijt6, Anita Wdowicz1, Andrea Mullins1, Katarzyna Kida1, Oktay I. Kaplan1,9, Sylvia E. C. van Beersum3,6,7, Ka Man Wu3,6,7, Stef J. F. Letteboer3,6,7, Dorus A. Mans3,6,7, Toshiaki Katada8, Kenji Kontani8, Marius Ueffing5,10", Ronald Roepman3,6,7", Hannie Kremer2,3,4,6", Oliver E. Blacque1* 1 School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland, 2 Department of Otorhinolaryngology, Radboud University Medical Center, Nijmegen, The Netherlands, 3 Nijmegen Centre for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands, 4 Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands, 5 Division of Experimental Ophthalmology and Medical Proteome Center, Center of Ophthalmology, University of Tu¨bingen, Tu¨bingen, Germany, 6 Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands, 7 Institute for Genetic and Metabolic Disease, Radboud University Medical Center, Nijmegen, The Netherlands, 8 Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan, 9 Berlin Institute for Medical Systems Biology (BIMSB) at Max-Delbru¨ck-Center for Molecular Medicine (MDC), Berlin, Germany, 10 Research Unit Protein Science, Helmholtz Zentrum Mu¨nchen, German Research Center for Environmental Health (GmbH), Neuherberg, Germany Abstract Cilia are microtubule-based cell appendages, serving motility, chemo-/mechano-/photo- sensation, and developmental signaling functions.
  • Polycystin-1 Regulates ARHGAP35-Dependent Centrosomal Rhoa Activation and ROCK Signaling

    Polycystin-1 Regulates ARHGAP35-Dependent Centrosomal Rhoa Activation and ROCK Signaling

    Polycystin-1 regulates ARHGAP35-dependent centrosomal RhoA activation and ROCK signaling Andrew J. Streets, … , Philipp P. Prosseda, Albert C.M. Ong JCI Insight. 2020;5(16):e135385. https://doi.org/10.1172/jci.insight.135385. Research Article Genetics Nephrology Graphical abstract Find the latest version: https://jci.me/135385/pdf RESEARCH ARTICLE Polycystin-1 regulates ARHGAP35- dependent centrosomal RhoA activation and ROCK signaling Andrew J. Streets, Philipp P. Prosseda, and Albert C.M. Ong Kidney Genetics Group, Academic Nephrology Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom. Mutations in PKD1 (encoding for polycystin-1 [PC1]) are found in 80%–85% of patients with autosomal dominant polycystic kidney disease (ADPKD). We tested the hypothesis that changes in actin dynamics result from PKD1 mutations through dysregulation of compartmentalized centrosomal RhoA signaling mediated by specific RhoGAP (ARHGAP) proteins resulting in the complex cellular cystic phenotype. Initial studies revealed that the actin cytoskeleton was highly disorganized in cystic cells derived from patients with PKD1 and was associated with an increase in total and centrosomal active RhoA and ROCK signaling. Using cilia length as a phenotypic readout for centrosomal RhoA activity, we identified ARHGAP5, -29, and -35 as essential regulators of ciliation in normal human renal tubular cells. Importantly, a specific decrease in centrosomal ARHGAP35 was observed in PKD1-null cells using a centrosome-targeted proximity ligation assay and by dual immunofluorescence labeling. Finally, the ROCK inhibitor hydroxyfasudil reduced cyst expansion in both human PKD1 3D cyst assays and an inducible Pkd1 mouse model. In summary, we report a potentially novel interaction between PC1 and ARHGAP35 in the regulation of centrosomal RhoA activation and ROCK signaling.
  • Molecular Studies of Phenotype Variation in Canine RPGR-XLPRA1

    Molecular Studies of Phenotype Variation in Canine RPGR-XLPRA1

    University of Pennsylvania ScholarlyCommons Departmental Papers (Vet) School of Veterinary Medicine 2016 Molecular Studies of Phenotype Variation in Canine RPGR- XLPRA1 Tatyana Appelbaum University of Pennsylvania Doreen Becker University of Pennsylvania Evelyn Santana University of Pennsylvania Gustavo D. Aguirre University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/vet_papers Part of the Veterinary Medicine Commons Recommended Citation Appelbaum, T., Becker, D., Santana, E., & Aguirre, G. D. (2016). Molecular Studies of Phenotype Variation in Canine RPGR-XLPRA1. Molecular Vision, 22 319-331. Retrieved from https://repository.upenn.edu/ vet_papers/148 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/vet_papers/148 For more information, please contact [email protected]. Molecular Studies of Phenotype Variation in Canine RPGR-XLPRA1 Abstract Purpose: Canine X-linked progressive retinal atrophy 1 (XLPRA1) caused by a mutation in retinitis pigmentosa (RP) GTPase regulator (RPGR) exon ORF15 showed significant ariabilityv in disease onset in a colony of dogs that all inherited the same mutant X chromosome. Defective protein trafficking has been detected in XLPRA1 before any discernible degeneration of the photoreceptors. We hypothesized that the severity of the photoreceptor degeneration in affected dogs may be associated with defects in genes involved in ciliary trafficking.o T this end, we examined six genes as potential disease modifiers. eW also examined the expression levels of 24 genes involved in ciliary trafficking (seven), visual pathway (five), neuronal maintenance genes (six), and cellular stress response (six) to evaluate their possible involvement in early stages of the disease. Methods: Samples from a pedigree derived from a single XLPRA1-affected male dog outcrossed to unrelated healthy mix-bred or purebred females were used for immunohistochemistry (IHC), western blot, mutational and haplotype analysis, and gene expression (GE).
  • Blueprint Genetics Nephronophthisis Panel

    Blueprint Genetics Nephronophthisis Panel

    Nephronophthisis Panel Test code: KI1901 Is a 20 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of nephronopthisis. The genes on this panel are included in the comprehensive Ciliopathy Panel. About Nephronophthisis Nephronophthisis (NPHP) is a heterogenous group of autosomal recessive cystic kidney disorders that represents the most frequent genetic cause of chronic and end-stage renal disease (ESRD) in children and young adults. It is characterized by chronic tubulointerstitial nephritis that progress to ESRD during the second decade (juvenile form) or before the age of five years (infantile form). Late-onset form of nephronophthisis is rare. The estimated prevalence is 1:100,000 individuals. NPHP may be seen with other clinical manifestations, such as liver fibrosis, situs inversus, cardiac malformations, intellectual deficiency, cerebellar ataxia, or bone anomalies. When NPHP is associated with cerebellar vermis aplasia/hypoplasia, retinal degeneration and mental retardation it is known as Joubert syndrome. When nephronophthisis is combined with retinitis pigmentosa, the disorder is known as Senior-Loken syndrome. In combination with multiple developmental and neurologic abnormalities, the disorder is often known as Meckel syndrome. Because most NPHP gene products localize to the cilium or its associated structures, nephronophthisis and the related syndromes have been termed ciliopathies. Availability 4 weeks Gene Set Description Genes in the Nephronophthisis Panel and their
  • Clinical Utility Gene Card For: Joubert Syndrome - Update 2013

    Clinical Utility Gene Card For: Joubert Syndrome - Update 2013

    European Journal of Human Genetics (2013) 21, doi:10.1038/ejhg.2013.10 & 2013 Macmillan Publishers Limited All rights reserved 1018-4813/13 www.nature.com/ejhg CLINICAL UTILITY GENE CARD UPDATE Clinical utility gene card for: Joubert syndrome - update 2013 Enza Maria Valente*,1,2, Francesco Brancati1, Eugen Boltshauser3 and Bruno Dallapiccola4 European Journal of Human Genetics (2013) 21, doi:10.1038/ejhg.2013.10; published online 13 February 2013 Update to: European Journal of Human Genetics (2011) 19, doi:10.1038/ejhg.2011.49; published online 30 March 2011 1. DISEASE CHARACTERISTICS 1.6 Analytical methods 1.1 Name of the disease (synonyms) Direct sequencing of coding genomic regions and splice site junctions; Joubert syndrome (JS); Joubert-Boltshauser syndrome; Joubert syn- multiplex microsatellite analysis for detection of NPHP1 homozygous drome-related disorders (JSRD), including cerebellar vermis hypo/ deletion. Possibly, qPCR or targeted array-CGH for detection of aplasia, oligophrenia, congenital ataxia, ocular coloboma, and hepatic genomic rearrangements in other genes. fibrosis (COACH) syndrome; cerebellooculorenal, or cerebello-oculo- renal (COR) syndrome; Dekaban-Arima syndrome; Va´radi-Papp 1.7 Analytical validation syndrome or Orofaciodigital type VI (OFDVI) syndrome; Malta Direct sequencing of both DNA strands; verification of sequence and syndrome. qPCR results in an independent experiment. 1.2 OMIM# of the disease 1.8 Estimated frequency of the disease 213300, 243910, 216360, 277170. (incidence at birth-‘birth prevalence’-or population prevalence) No good population-based data on JSRD prevalence have been published. A likely underestimated frequency between 1/80 000 and 1.3 Name of the analysed genes or DNA/chromosome segments 1/100 000 live births is based on unpublished data.
  • Characterization of Primary Cilia and Intraflagellar Transport 20 in the Epidermis

    Characterization of Primary Cilia and Intraflagellar Transport 20 in the Epidermis

    Characterization of Primary Cilia and Intraflagellar Transport 20 in the Epidermis Steven H. Su Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2020 © 2020 Steven H. Su All Rights Reserved Abstract Characterization of Primary Cilia and Intraflagellar Transport 20 in the Epidermis Steven H. Su Mammalian skin is a dynamic organ that constantly undergoes self-renewal during homeostasis and regenerates in response to injury. Crucial for the skin’s self-renewal and regenerative capabilities is the epidermis and its stem cell populations. Here we have interrogated the role of primary cilia and Intraflagellar Transport 20 (Ift20) in epidermal development as well as during homeostasis and wound healing in postnatal, adult skin. Using a transgenic mouse model with fluorescent markers for primary cilia and basal bodies, we characterized epidermal primary cilia during embryonic development as well as in postnatal and adult skin and find that both the Interfollicular Epidermis (IFE) and hair follicles (HFs) are highly ciliated throughout development as well as in postnatal and adult skin. Leveraging this transgenic mouse, we also developed a technique for live imaging of epidermal primary cilia in ex vivo mouse embryos and discovered that epidermal primary cilia undergo ectocytosis, a ciliary mechanism previously only observed in vitro. We also generated a mouse model for targeted ablation of Ift20 in the hair follicle stem cells (HF-SCs) of adult mice. We find that loss of Ift20 in HF-SCs inhibits ciliogenesis, as expected, but strikingly it also inhibits hair regrowth.
  • REPORT CC2D2A, Encoding a Coiled-Coil and C2 Domain Protein, Causes Autosomal-Recessive Mental Retardation with Retinitis Pigmentosa

    REPORT CC2D2A, Encoding a Coiled-Coil and C2 Domain Protein, Causes Autosomal-Recessive Mental Retardation with Retinitis Pigmentosa

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REPORT CC2D2A, Encoding A Coiled-Coil and C2 Domain Protein, Causes Autosomal-Recessive Mental Retardation with Retinitis Pigmentosa Abdul Noor,1 Christian Windpassinger,1,2 Megha Patel,1 Beata Stachowiak,1 Anna Mikhailov,1 Matloob Azam,3 Muhammad Irfan,4 Zahid Kamal Siddiqui,5 Farooq Naeem,6 Andrew D. Paterson,7 Muhammad Lutfullah,8 John B. Vincent,1,* and Muhammad Ayub9 Autosomal-recessive inheritance is believed to be relatively common in mental retardation (MR), although only four genes for nonsyn- dromic autosomal-recessive mental retardation (ARMR) have been reported. In this study, we ascertained a consanguineous Pakistani family with ARMR in four living individuals from three branches of the family, plus an additional affected individual later identified as a phenocopy. Retinitis pigmentosa was present in affected individuals, but no other features suggestive of a syndromic form of MR were found. We used Affymetrix 500K microarrays to perform homozygosity mapping and identified a homozygous and haploidentical region of 11.2 Mb on chromosome 4p15.33-p15.2. Linkage analysis across this region produced a maximum two-point LOD score of 3.59. We sequenced genes within the critical region and identified a homozygous splice-site mutation segregating in the family, within a coiled-coil and C2 domain-containing gene, CC2D2A. This mutation leads to the skipping of exon 19, resulting in a frameshift and a truncated protein lacking the C2 domain. Conservation analysis for CC2D2A suggests a functional domain near the C terminus as well as the C2 domain.